LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

HomeStock ListAldeyra Therapeutics Inc

Aldeyra Therapeutics Inc

Closed

3.87 -6.97

Overview

Share price change

24h

Current

Min

3.85

Max

4.16

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+123.53 upside

Dividends

By Dow Jones

Next Earnings

2 May 2024

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Aldeyra Therapeutics Inc Chart

Related News

1 Nov 2023, 18:12 UTC

Major Market Movers

Aldeyra Shares Continue to Rally After AbbVie Agrees to Licensing Option

16 Oct 2023, 13:25 UTC

Major Market Movers

Aldeyra Therapeutics Shares Fall 73% After Warning That FDA Might Not Approve Drug

21 Jun 2023, 17:08 UTC

Major Market Movers

Aldeyra Therapeutics Stock Down 24% After FDA Rejects Eye Cancer Treatment

21 Jun 2023, 14:18 UTC

Major Market Movers

Aldeyra Therapeutics Says FDA Cites Lack of Evidence For PVRL Drug

15 Jun 2023, 16:56 UTC

Major Market Movers

Aldeyra Therapeutics Shares Rise 11% After Positive Data for Reproxalap

Peer Comparison

Price change

Aldeyra Therapeutics Inc forecast

Price Target

By TipRanks

123.53% upside

12 Months Forecast

Average 9.5 USD  123.53%

High 11 USD

Low 7 USD

Based on 5 Wall Street analysts offering 12 month price targets forAldeyra Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

3.55 / 4.48Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence